{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:39:41Z","timestamp":1792431581479,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2025JC-YBQN-1266"],"award-info":[{"award-number":["2025JC-YBQN-1266"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.exger.2026.113319","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:21:41Z","timestamp":1788970901000},"page":"113319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Drug-associated osteoarthritis signals in FAERS: A pharmacovigilance study"],"prefix":"10.1016","volume":"224","author":[{"given":"Honghao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9906","key":"10.1016\/j.exger.2026.113319_bb0005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.exger.2026.113319_bb0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-024-01143-3","article-title":"The role of obesity and adipose tissue dysfunction in osteoarthritis pain","volume":"20","author":"Binvignat","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.exger.2026.113319_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1390387","article-title":"Exploring the causal link among statin drugs and the osteoarthritis risk based on Mendelian randomization research","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.exger.2026.113319_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297766","article-title":"Assessing the causal associations of different types of statins use and knee\/hip osteoarthritis: a Mendelian randomization study","volume":"19","author":"Chen","year":"2024","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.exger.2026.113319_bb0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41584-021-00650-x","article-title":"Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis","volume":"17","author":"Ching","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.exger.2026.113319_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14040228","article-title":"Iron absorption: molecular and pathophysiological aspects","volume":"14","author":"Correnti","year":"2024","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.exger.2026.113319_bb0035","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.joca.2024.07.014","article-title":"Osteoarthritis year in review 2024: epidemiology and therapy","volume":"32","author":"Courties","year":"2024","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.exger.2026.113319_bb0040","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.joca.2025.08.015","article-title":"Osteoarthritis year in review 2025: epidemiology and therapy","volume":"33","author":"Dell\u2019Isola","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.exger.2026.113319_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.joca.2023.11.018","article-title":"Aging and the emerging role of cellular senescence in osteoarthritis","volume":"32","author":"Diekman","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.exger.2026.113319_bb0050","article-title":"Post-traumatic osteoarthritis: a review of pathogenic mechanisms and novel targets for mitigation","volume":"18","author":"Dilley","year":"2023","journal-title":"Bone Rep."},{"key":"10.1016\/j.exger.2026.113319_bb0055","article-title":"Leveraging real-world data for safety signal detection and risk management in pre- and post-market settings","volume":"5","author":"Gavin","year":"2025","journal-title":"Front. Drug Saf. Regul."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1186\/s12891-022-05900-x","article-title":"Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study","volume":"23","author":"Gill","year":"2022","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.exger.2026.113319_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1404427","article-title":"Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.exger.2026.113319_bb0070","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1007\/s10787-025-01890-z","article-title":"The renin-angiotensin system (RAS) and arthritic diseases: therapeutic potential for RAS inhibitors","volume":"33","author":"Habib","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.exger.2026.113319_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-025-02278-7","article-title":"The potential of authorised drugs to be repurposed for the treatment of osteoarthritis: a scoping review of clinical studies","volume":"86","author":"Heijman","year":"2026","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0080","doi-asserted-by":"crossref","first-page":"21341","DOI":"10.1038\/s41598-025-05709-3","article-title":"Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024","volume":"15","author":"Hong","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41413-021-00147-z","article-title":"Subchondral bone microenvironment in osteoarthritis and pain","volume":"9","author":"Hu","year":"2021","journal-title":"Bone Res."},{"issue":"12","key":"10.1016\/j.exger.2026.113319_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13121647","article-title":"Clinical and biochemical implications of hyaluronic acid in musculoskeletal rehabilitation: a comprehensive review","volume":"13","author":"Iaconisi","year":"2023","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.joca.2024.10.008","article-title":"Osteoarthritis year in review 2024: biology","volume":"33","author":"Jenei-Lanzl","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.exger.2026.113319_bb0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and treatment of hip and knee osteoarthritis: a review","volume":"325","author":"Katz","year":"2021","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41413-025-00431-2","article-title":"AIDS patients suffer higher risk of advanced knee osteoarthritis progression due to lopinavir-induced Zmpste24 inhibition","volume":"13","author":"Kong","year":"2025","journal-title":"Bone Res."},{"issue":"8","key":"10.1016\/j.exger.2026.113319_bb0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.joca.2024.05.008","article-title":"Repurposing drugs for the treatment of osteoarthritis","volume":"32","author":"Kuswanto","year":"2024","journal-title":"Osteoarthr. Cartil."},{"issue":"17","key":"10.1016\/j.exger.2026.113319_bb0115","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by indication in clinical research","volume":"316","author":"Kyriacou","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.exger.2026.113319_bb0120","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol."},{"issue":"4","key":"10.1016\/j.exger.2026.113319_bb0125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s12672-024-01642-5","article-title":"Unraveling the causal relationship and potential mechanisms between osteoarthritis and breast cancer: insights from mendelian randomization and bioinformatics analysis","volume":"15","author":"Li","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12891-019-2573-5","article-title":"Is treated HIV infection associated with knee cartilage degeneration and structural changes? A longitudinal study using data from the osteoarthritis initiative","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"issue":"7","key":"10.1016\/j.exger.2026.113319_bb0140","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-025-06493-0","article-title":"A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases","volume":"25","author":"Lou","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"14","key":"10.1016\/j.exger.2026.113319_bb0150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2026.113319_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676173","article-title":"Interleukin-17A causes osteoarthritis-like transcriptional changes in human osteoarthritis-derived chondrocytes and synovial fibroblasts in vitro","volume":"12","author":"Mimpen","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/ard.27.1.71","article-title":"Inhibition of ascorbic-acid-induced depolymerization of hyaluronic acid by ceruloplasmin in synovial fluid","volume":"27","author":"Niedermeier","year":"1968","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0165","doi-asserted-by":"crossref","first-page":"15293","DOI":"10.1038\/s41598-025-92247-7","article-title":"Risk of knee osteoarthritis in patients with multiple atopic conditions: a nationwide study","volume":"15","author":"Park","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.exger.2026.113319_bb0175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s13679-023-00520-5","article-title":"Obesity, metabolic syndrome, and osteoarthritis-an updated review","volume":"12","author":"Sampath","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.exger.2026.113319_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109633","article-title":"Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells","volume":"72","author":"Shang","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exger.2026.113319_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113733","article-title":"IL-17A exacerbates synovial inflammation in osteoarthritis via activation of endoplasmic reticulum stress","volume":"145","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","article-title":"Current understanding of osteoarthritis pathogenesis and relevant new approaches","volume":"10","author":"Tong","year":"2022","journal-title":"Bone Res."},{"issue":"10","key":"10.1016\/j.exger.2026.113319_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102572","article-title":"Cardiovascular drugs and osteoarthritis: effects of targeting ion channels","volume":"10","author":"Vaiciuleviciute","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0210","article-title":"IL-17 in osteoarthritis: a narrative review","volume":"18","author":"Xiao","year":"2023","journal-title":"Open Life Sci."},{"key":"10.1016\/j.exger.2026.113319_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jot.2020.09.006","article-title":"Chondrocyte ferroptosis contribute to the progression of osteoarthritis","volume":"27","author":"Yao","year":"2021","journal-title":"J. Orthop. Translat."},{"key":"10.1016\/j.exger.2026.113319_bb0220","article-title":"The association between statin use and osteoarthritis-related outcomes: an updated systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41413-022-00231-y","article-title":"Runx1 is a key regulator of articular cartilage homeostasis by orchestrating YAP, TGF\u03b2, and Wnt signaling in articular cartilage formation and osteoarthritis","volume":"10","author":"Zhang","year":"2022","journal-title":"Bone Res."},{"issue":"11","key":"10.1016\/j.exger.2026.113319_bb0230","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s40520-023-02530-8","article-title":"Effects of blood pressure and antihypertensive drugs on osteoarthritis: a Mendelian randomized study","volume":"35","author":"Zhang","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.exger.2026.113319_bb0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41413-021-00173-x","article-title":"Runx1 protects against the pathological progression of osteoarthritis","volume":"9","author":"Zhou","year":"2021","journal-title":"Bone Res."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556526002986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556526002986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:44:15Z","timestamp":1792428255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556526002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0531556526002986"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2026.113319","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-associated osteoarthritis signals in FAERS: A pharmacovigilance study","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2026.113319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113319"}}